EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Variant rs4986790 of toll-like receptor 4 affects the signaling and induces cell dysfunction in patients with severe COVID-19

Julio Flores-Gonzalez, Leslie Chavez-Galan, Ramcés Falfán-Valencia, Ivette Buendía Roldán, Ingrid Fricke-Galindo, Abigail Veronica-Aguilar, Alfonso Martínez-Morales, Rafael de Jesús Hernández-Zenteno, Iris Paola Guzmán-Guzmán, Gloria Pérez-Rubio

International Journal of Infectious Diseases · 2024

DOI: 10.1016/j.ijid.2023.11.032 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Infectious Diseases, 2024. Verfasst von Julio Flores-Gonzalez und 9 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Integrative Immunology, Instituto Nacional de Enfermedades Respiratorias Ismael Cosio Villegas, Mexico City, Mexico. Hauptthemen laut MEDLINE: COVID-19, Toll-Like Receptor 4. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVES: We investigated the expression of toll-like receptor (TLR)-4 on the cell surface of innate and adaptive cells from patients with COVID-19 carrying the rs4986790 GG genotype in the TLR4 gene and the functional profile of these cells. METHODS: We included 1169 hospitalized patients with COVID-19. The rs4986790 in TLR4 was identified by real-time polymerase chain reaction. Peripheral blood mononuclear cells were isolated and cultured to evaluate TLR-4 expression on immune cells. Supernatants recovered culture assays were stored, and we measured cytokines and cytotoxic molecules. RESULTS: We showed that the rs4986790 (GG) was significantly associated (P = 0.0310) with severe COVID-19. Cells of patients with COVID-19 carrying the GG genotype have increased the frequency of monocytes and activated naïve and non-switched B cells positive to TLR-4 when cells are stimulated with lipopolysaccharide and with spike protein of SARS-CoV-2. Also, cells from patients with GG COVID-19 cannot produce pro-inflammatory cytokines after lipopolysaccharide stimulus, but they are high producers of cytotoxic molecules at baseline. CONCLUSIONS: The rs4986790 GG genotype of the TLR4 is associated with the risk of COVID-19 and acute respiratory distress syndrome. Peripheral blood mononuclear cells of patients carrying the rs4986790 (TLR4) GG genotype had a limited delivery of pro-inflammatory cytokines compared to the AA and AG genotypes in which TLR-4 stimulation induces IL-10, IL-6, tumor necrosis factor-α, and Fas ligand production.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Toll-Like Receptor 4HumansCytokinesLeukocytes, MononuclearLipopolysaccharidesSARS-CoV-2GenotypeSeverity of Illness Index

Stichwörter der Autor:innen

B cellCD8+ T cellCOVID-19MonocytesPolymorphismTLR4

Substanzen

CytokinesLipopolysaccharidesToll-Like Receptor 4TLR4 protein, human

Autor:innen und Institutionen

  • Laboratory of Integrative Immunology, Instituto Nacional de Enfermedades Respiratorias Ismael Cosio Villegas, Mexico City, Mexico.
  • HLA Laboratory, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico City, Mexico.
  • Translational Research Laboratory on Aging and Pulmonary Fibrosis, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico City, Mexico.
  • COPD Clinic, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico City, Mexico.
  • Faculty of Chemical-Biological Sciences, Universidad Autónoma de Guerrero, Chilpancingo, Guerrero, Mexico.
  • HLA Laboratory, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico City, Mexico. Electronic address: glofos@yahoo.com.mx.

Zitieren

APA

Flores-Gonzalez, J., Chavez-Galan, L., Falfán-Valencia, R., Roldán, I. B., Fricke-Galindo, I., Veronica-Aguilar, A., Martínez-Morales, A., Hernández-Zenteno, R. J., Guzmán-Guzmán, I. P., & Pérez-Rubio, G. (2024). Variant rs4986790 of toll-like receptor 4 affects the signaling and induces cell dysfunction in patients with severe COVID-19. International Journal of Infectious Diseases. https://doi.org/10.1016/j.ijid.2023.11.032

Vancouver

Flores-Gonzalez J, Chavez-Galan L, Falfán-Valencia R, Roldán IB, Fricke-Galindo I, Veronica-Aguilar A, et al. Variant rs4986790 of toll-like receptor 4 affects the signaling and induces cell dysfunction in patients with severe COVID-19. International Journal of Infectious Diseases. 2024. doi:10.1016/j.ijid.2023.11.032

BibTeX
@article{FloresGonzalez2024,
  author = {Flores-Gonzalez, Julio and Chavez-Galan, Leslie and Falfán-Valencia, Ramcés and Roldán, Ivette Buendía and Fricke-Galindo, Ingrid and Veronica-Aguilar, Abigail and Martínez-Morales, Alfonso and Hernández-Zenteno, Rafael de Jesús and Guzmán-Guzmán, Iris Paola and Pérez-Rubio, Gloria},
  title = {Variant rs4986790 of toll-like receptor 4 affects the signaling and induces cell dysfunction in patients with severe COVID-19},
  journal = {International Journal of Infectious Diseases},
  year = {2024},
  doi = {10.1016/j.ijid.2023.11.032}
}
Kostenlos starten →